Northern Capital Management (Wisconsin)’s iShares Biotechnology ETF IBB Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$2.69M	Buy	27,920 +2,155	+8%	+$229K	0.72%	60
2018 Q3	$3.14M	Buy	25,765 +55	+0.2%	+$6.48K	0.72%	57
2018 Q2	$2.82M	Buy	25,710 +2,520	+11%	+$270K	0.69%	61
2018 Q1	$2.48M	Buy	23,190 +790	+4%	+$87.6K	0.64%	60
2017 Q4	$2.39M	Buy	22,400 +15,500	+225%	+$1.66M	0.62%	61
2017 Q3	$767K	Buy	6,900 +3,150	+84%	+$337K	0.24%	117
2017 Q2	$388K	Buy	3,750 +105	+3%	+$10.3K	0.14%	133
2017 Q1	$356K	Buy	3,645 +300	+9%	+$28.7K	0.14%	129
2016 Q4	$296K	Buy	3,345 +525	+19%	+$47.8K	0.12%	124
2016 Q3	$272K	Hold	2,820	–	–	0.12%	120
2016 Q2	$242K	Buy	2,820 +150	+6%	+$13.5K	0.11%	125
2016 Q1	$232K	Hold	2,670	–	–	0.1%	135
2015 Q4	$301K	Hold	2,670	–	–	0.13%	130
2015 Q3	$270K	Hold	2,670	–	–	0.12%	137
2015 Q2	$328K	Hold	2,670	–	–	0.15%	118
2015 Q1	$306K	Hold	2,670	–	–	0.15%	117
2014 Q4	$270K	Hold	2,670	–	–	0.13%	118
2014 Q3	$244K	Sell	2,670 -300	-10%	-$26.3K	0.12%	120
2014 Q2	$254K	Hold	2,970	–	–	0.13%	132
2014 Q1	$234K	Hold	2,970	–	–	0.12%	132
2013 Q4	$225K	Hold	2,970	–	–	0.12%	129
2013 Q3	$208K	Buy	+2,970	New	+$195K	0.12%	123

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s IBB Position: Q4 2018 in Review

Northern Capital Management (Wisconsin) increased its iShares Biotechnology ETF (IBB) stake by 8.4% in Q4 2018, buying an estimated $229K and bringing the position to 27,920 shares worth $2.69M. The position accounts for 0.72% of the portfolio, ranked #60.

Northern Capital Management (Wisconsin) first reported a position in IBB in Q3 2013 and has held it in 22 quarters since. The position peaked at $3.14M in Q3 2018. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

Northern Capital Management (Wisconsin) held 27,920 shares of iShares Biotechnology ETF worth $2.69M as of Q4 2018.
Northern Capital Management (Wisconsin) bought 2,155 iShares Biotechnology ETF shares in Q4 2018, an estimated $229K.
iShares Biotechnology ETF made up 0.72% of Northern Capital Management (Wisconsin)'s portfolio in Q4 2018, its #60 holding.
Northern Capital Management (Wisconsin) first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 22 quarters since.
Northern Capital Management (Wisconsin)'s iShares Biotechnology ETF position peaked at $3.14M in Q3 2018.
649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q4 2018, filed 1 Feb 2019.